HSBC cuts PT for Novo Nordisk to DKK 280 from DKK 320; cuts PT for Bristol-Myers Squibb to $60 from $65; cuts PT for AstraZeneca to 13,900 pence from 13,920 pence.

2026-10-19

HSBC cuts PT for Novo Nordisk to DKK 280 from DKK 320; cuts PT for Bristol-Myers Squibb to $60 from $65; cuts PT for AstraZeneca to 13,900 pence from 13,920 pence.